News

NIH-funded study shows children on newer regimens closer to normal timetable.

Using human iPSC’s and DNA-cutting protein from meningitis bacteria, researchers have created an efficient way to target and repair defective genes.

Scientists have worked out how two bacterial strains delay cell division when food is abundant.

A chemist has received a federal grant to study the oral administration of PYY3-36, a peptide that inhibits food intake by naturally switching off one's appetite.

A team of chemists has used a temperature-sensitive polymer to regulate DNA interactions in both a DNA-mediated assembly system and a DNA-encoded drug-delivery system.

Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.

Company has joined an EU-funded consortium focused on the discovery of microRNA medicines in the area of cardiac and inflammatory metabolic diseases.

Appointment of Dr. Gualtiero Guadagni as the Company's Vice President.

Researchers will investigate the emerging field of extracellular RNA and its role in human health conditions.

Porvair’s new version of chemical compatibility chart.